ClinConnect ClinConnect Logo
Search / Trial NCT05384860

Incorporating Acupuncture Into ERAS for Ambulatory Total Hip Replacement (THR) Surgery

Launched by HOSPITAL FOR SPECIAL SURGERY, NEW YORK · May 18, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Hip Surgery Acupuncture

ClinConnect Summary

This clinical trial is exploring the use of acupuncture to help patients recover more quickly after total hip replacement (THR) surgery. The goal is to see if adding acupuncture during surgery can reduce the need for opioid pain medications and shorten the time patients spend in the hospital. By testing this approach, researchers hope to create a better recovery plan that combines multiple methods to improve patient outcomes.

To participate in this study, you need to be between 18 and 80 years old, be scheduled for a total hip replacement, and be able to follow the study guidelines. You should also be in good health (ASA status of 1 or 2) and speak English. However, if you have been using opioids for a long time, have certain medical conditions, or have specific issues with your ears, you may not be eligible. If you join the trial, you can expect to receive acupuncture during your surgery, which is a safe and low-cost treatment that may help you recover more effectively.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • ASA status of 1 or 2
  • Ages 18-80
  • Undergoing a total hip replacement
  • Ability to follow study protocol
  • English-speaking
  • Exclusion Criteria:
  • Non-English speaking
  • Chronic opioids use (6 weeks or more)
  • Contraindication to neuraxial anesthesia or peripheral nerve block
  • Intending to receive general anesthesia
  • Contraindication to intra-op protocol
  • Implanted cardiac device (i.e. pacemaker)
  • Active ear infection
  • Non-native ear, previous scarring or surgery
  • Ear gauges or other deforming ear piercing
  • Allergy to Nickel

About Hospital For Special Surgery, New York

The Hospital for Special Surgery (HSS) in New York is a world-renowned institution specializing in orthopedic surgery, rheumatology, and rehabilitation. Recognized for its commitment to advancing medical research and improving patient outcomes, HSS serves as a leading clinical trial sponsor, facilitating innovative studies that explore cutting-edge treatments and therapies. With a team of expert clinicians and researchers, HSS aims to enhance clinical practices through rigorous scientific inquiry, ultimately contributing to the advancement of musculoskeletal health and patient care on a global scale.

Locations

New York, New York, United States

Patients applied

0 patients applied

Trial Officials

Stephanie Cheng, MD

Principal Investigator

Hospital for Special Surgery, New York

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials